WE ARE living in the "Golden Age" of dermatologic therapy, or so it would seem. During the decade since sulfanilamide was first introduced into therapy a procession of new potent drugs has been added to our weapons against disease. With the sulfonamide compounds in all their many variations; with penicillin, streptomycin, tyrothricin, bacitracin, aureomycin and other antibiotics yet to be named; with the vitamins in all their fractionations; with radioactive isotopes, and with the host of antihistaminic drugs it would seem that the therapeutic progress in these few years is unmatched in any period in history. Only time and the merciless inroads of experience will tell whether these contributions will live through the ages as permanent achievements, as have the artistic wonders of the "Golden Age of Pericles."
It is unfortunate that all these drugs have appeared on the scene as "wonder drugs." Such an introductory appraisal is not conducive
CARO MR. OLD DERMATOLOGIC DRUGS WHICH SHOULD BE RETAINED. Arch Derm Syphilol. 1949;60(6):1077–1089. doi:10.1001/archderm.1949.01530070017002
Dermatology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.